Universiteit Maastricht

The medical center is at the forefront of hematology and oncology, focusing on innovative treatments for B-cell Non-Hodgkin Lymphoma. Through the exploration of epcoritamab combinations, the center aims to enhance therapeutic outcomes and improve patient safety and tolerability.

• B-cell Non-Hodgkin Lymphoma
• Combination Therapies
• Safety and Tolerability

By integrating cutting-edge research with clinical practice, the center contributes significantly to the advancement of cancer treatment protocols.

Specializing in systemic lupus erythematosus (SLE), the center is dedicated to evaluating the efficacy of dapirolizumab pegol as an adjunct therapy. This research is pivotal in achieving long-term improvements in disease activity for patients with moderate to severe SLE.

• Systemic Lupus Erythematosus (SLE)
• Adjunct Therapies
• Long-term Disease Management

The center's work in rheumatology is instrumental in developing new standards of care for autoimmune diseases.

Focusing on a range of solid tumors, including liver, colon, and pancreatic cancers, the center investigates the combination of pembrolizumab, lenvatinib, and belzutifan. This research aims to improve response rates and patient outcomes.

• Liver Cancer
• Colon Cancer
• Pancreatic Cancer

The center's innovative approach in solid tumor research is paving the way for more effective cancer therapies.

In the field of cardiology, the center is committed to understanding the long-term safety of aficamten in patients with symptomatic hypertrophic cardiomyopathy (HCM). This research is crucial for improving the quality of life for individuals with HCM.

• Hypertrophic Cardiomyopathy (HCM)
• Long-term Safety
• Quality of Life

The center's contributions to cardiology research are vital in developing safer and more effective treatments for heart conditions.

Specializing in non-small cell lung cancer (NSCLC), the center evaluates the efficacy of durvalumab and osimertinib in combination with radiation therapy. This research is essential for advancing treatment options for early-stage NSCLC.

• Non-small Cell Lung Cancer (NSCLC)
• Radiation Therapy
• Targeted Therapies

The center's work in respiratory oncology is crucial for improving survival rates and treatment efficacy in lung cancer patients.

Focusing on metastatic renal cell carcinoma (mRCC), the center compares the efficacy of immune checkpoint inhibitors and VEGFR TKI combinations. This research is pivotal in enhancing survival outcomes for patients with mRCC.

• Metastatic Renal Cell Carcinoma (mRCC)
• Immune Checkpoint Inhibitors
• VEGFR TKI Combinations

The center's research in renal oncology is instrumental in developing personalized treatment strategies for kidney cancer.

In the realm of breast cancer, the center investigates the efficacy of imlunestrant and abemaciclib in advanced ER+, HER2- cases. This research is crucial for optimizing endocrine therapy and improving progression-free survival.

• Advanced Breast Cancer
• Endocrine Therapy
• Progression-Free Survival

The center's contributions to breast cancer research are vital in advancing treatment options and patient care.

Specializing in myotonic dystrophy, the center evaluates the safety of VX-670 in patients with this condition. This research is essential for developing new therapeutic approaches for neuromuscular disorders.

• Myotonic Dystrophy
• Neuromuscular Disorders
• Therapeutic Approaches

The center's work in neuromuscular research is crucial for improving treatment options and patient outcomes.

In the field of gynecologic oncology, the center explores the safety of replacing traditional surgery with chemoradiation in vulvar cancer patients. This research is pivotal in reducing treatment invasiveness and improving patient quality of life.

• Vulvar Cancer
• Chemoradiation
• Minimally Invasive Treatments

The center's contributions to gynecologic oncology are vital in advancing less invasive treatment options for women.

Focusing on stroke in young adults, the center investigates the impact of discontinuing antiplatelet therapy. This research is crucial for understanding long-term cardiovascular outcomes and optimizing stroke management.

• Stroke
• Antiplatelet Therapy
• Cardiovascular Outcomes

The center's work in neurology is instrumental in developing evidence-based guidelines for stroke prevention and management.